Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT05329532 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer
Renal Cell Cancer
High Grade Ovarian Serous Adenocarcinoma
Squamous Cell Carcinoma of the Head and Neck

Interventions

BIOLOGICAL: Modi-1 Moditope
BIOLOGICAL: Pembrolizumab
DEVICE: MicronJet600™ microneedle device (NanoPass)

Sponsor

Scancell Ltd